Therapeutic Potential of Centhaquine Citrate, a Selective Alpha-2B Adrenoceptor Agonist, in the Management of Circulatory Shock.

Drugs · 2025 · PMC12098521 · PMID 40253656

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

showed a trendp = 0.11not close (p > 0.1)

MODS from day 3 to day 7 showed a trend toward improvement in the centhaquine group (MODS 1.37 to 0.82, p = 0.11) and toward deterioration in the control group (MODS 1.14 to 1.73) [ 30 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.